Clinical Trial Update: Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma has completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-clear Cell Renal Cell Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Advanced Non-Clear Cell Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21